Literature DB >> 24891432

Frequent carriage of resistance mechanisms to β-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children.

Silvia García-Cobos1, Miriam Moscoso2, Félix Pumarola3, Margarita Arroyo4, Noelia Lara4, María Pérez-Vázquez4, Belén Aracil4, Jesús Oteo4, Ernesto García2, José Campos5.   

Abstract

OBJECTIVES: Non-typeable Haemophilus influenzae are a major cause of acute otitis media (AOM), including chronic and recurrent otitis in young children. The objective of this study was to determine whether non-typeable H. influenzae isolates causing these infections produce biofilms and carry resistance mechanisms to β-lactams.
METHODS: A collection of 48 H. influenzae isolates was obtained by tympanocentesis or from otorrhoea samples from individual patients <3 years of age and diagnosed with recurrent or treatment failure AOM. Each isolate was surveyed for the presence of blaTEM genes, amino acid substitutions in the transpeptidase domain of penicillin-binding protein 3 (PBP3) and biofilm formation in microtitre plates.
RESULTS: In 43 of the 48 isolates (89.6%), at least one of the three tested conditions was identified: biofilm formation (83.3%) and resistance mechanisms to β-lactams (33.3%), modifications in the transpeptidase domain of PBP3 being the most prevalent (22.9%), followed by β-lactamase production (10.4%). Additionally, 13 (27.1%) isolates had two or more of these three traits. In relation to biofilm formation, those isolates with an amoxicillin MIC ≤ 0.5 mg/L had higher optical density values than isolates with an amoxicillin MIC ≥ 1 mg/L (Mann-Whitney U-test, P=0.048).
CONCLUSIONS: These findings suggest that the successful treatment of non-typeable H. influenzae causing chronic and recurrent AOM in young children may be compromised by the high biofilm-forming capacity of the isolates and the presence of β-lactam resistance mechanisms, particularly PBP3 mutations.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AOM; H. influenzae; gBLNAR

Mesh:

Year:  2014        PMID: 24891432     DOI: 10.1093/jac/dku158

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Role of biofilm in children with recurrent upper respiratory tract infections.

Authors:  E Nazzari; S Torretta; L Pignataro; P Marchisio; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-16       Impact factor: 3.267

2.  Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size.

Authors:  Jennifer L Reimche; Daniel J Kirse; Amy S Whigham; W Edward Swords
Journal:  Pathog Dis       Date:  2016-12-11       Impact factor: 3.166

3.  N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.

Authors:  Mirian Domenech; Ernesto García
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 4.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

5.  Evidence of the presence of nucleic acids and β-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms.

Authors:  Mirian Domenech; Elena Pedrero-Vega; Alicia Prieto; Ernesto García
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

6.  Microbial virulence, molecular epidemiology and pathogenic factors of fluoroquinolone-resistant Haemophilus influenzae infections in Guangzhou, China.

Authors:  Dingqiang Chen; Shuxian Wen; Donghua Feng; Ruirui Xu; Junyan Liu; Brian M Peters; Danhong Su; Yongping Lin; Ling Yang; Zhenbo Xu; Mark E Shirtliff
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-11-23       Impact factor: 3.944

7.  Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.

Authors:  M Ibar-Bariain; A Rodríguez-Gascón; A Isla; M A Solinís; A Canut-Blasco
Journal:  Rev Esp Quimioter       Date:  2019-02-05       Impact factor: 1.553

8.  Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis.

Authors:  Urszula Kosikowska; Paweł Rybojad; Dagmara Stępień-Pyśniak; Anna Żbikowska; Anna Malm
Journal:  BMC Infect Dis       Date:  2016-08-26       Impact factor: 3.090

9.  Fluorescence Imaging of Streptococcus pneumoniae with the Helix pomatia agglutinin (HPA) As a Potential, Rapid Diagnostic Tool.

Authors:  Mirian Domenech; Ernesto García
Journal:  Front Microbiol       Date:  2017-07-18       Impact factor: 5.640

10.  Changes Over Time in Nasopharyngeal Colonization in Children Under 2 Years of Age at the Time of Diagnosis of Acute Otitis Media (1999-2014).

Authors:  Judith M Martin; Alejandro Hoberman; Nader Shaikh; Timothy Shope; S Onika Bhatnagar; Stan L Block; Mary Ann Haralam; Marcia Kurs-Lasky; Michael Green
Journal:  Open Forum Infect Dis       Date:  2018-02-17       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.